Although CK7 is a very sensitive marker for screening malignant cells in third cavity fluids, which is essential for the first panel, it can be expressed at variable levels in a broad-spectrum of cancers, including pancreatic, biliary tract, colon, breast, and lung, to evoke malignant ascites. The gene discussed is KRT7; the disease is cancer.